期刊文献+

Mina53、Ki-67在中国人大肠癌中的表达及其与临床病理学之间的关系 被引量:6

Expression and Clinical Significance of Mina53 and Ki-67 in colorectal carcinoma
下载PDF
导出
摘要 目的 检测Mina53、Ki-67在大肠癌中的表达水平,研究其与临床病理学之间的关系,判断其表达对预后的意义,为大肠癌的早期诊断预防和治疗提供分子生物学依据.方法 收集长江大学附属第一医院,荆州市第一人民医院2004年12月-2006年12月大肠癌手术治疗的标本82例,应用免疫组化SP法检测组织切片中Mina53、Ki-67的表达,并与临床特征、病理分级等因素进行相关性分析.结果 82例大肠癌组织标本中,Mina53以及Ki-67均为核染色,Mina53阳性表达率为78.05%(64/82),Ki-67阳性表达率为80.49%(66/82);Spearman相关性检验显示,Mina53表达与Ki-67表达呈正相关(P=0.000),Mina53、Ki-67表达水平与分期相关,P值分别为0.029、0.037,Mina53、Ki-67表达水平越高,分期越晚.与年龄、肿块大小以及病理学分级无关;Cox回归分析显示,Mina53表达、术后分期与预后相关,P值分别为0.039、0.000,而Ki-67表达、病理分级、肿块大小与预后无关.结论 Mina53、Ki-67在大肠癌细胞中呈特异性高表达,且Mina53表达水平与Ki-67表达水平明显相关,两者的高表达提示肿瘤易出现淋巴结转移及远处转移,Mina53可能成为判断大肠癌预后的因素之一. Objective To investigate the expression of MinaS3 and Ki -67 in the human colorectal car- cinoma, and the correlation between the expression and the clinicopathology, study the clinical significance of Mi- naS3 and Ki -67 in colorectal carcinoma, and afford a new molecule biological evidence and method for earlier diagnosis, prevention and therapy of colorectal cancer. Method 82 specimens of different colorectal carcinoma tissue were collected by surgery in the first people's hospital in Jingzhou between Dec. 2004 and Dec. 2006. All of the specimens were detected with the immunhistochemical method of SP by the MinaS3 antibody and the Ki -67 antibody, respectively. The relationship between the expression of MinaS3, Ki - 67 and the clinicopathology were analyed by SPSS13.0. Results The positive rates of the expression of MinaS3 and Ki - 67 were 78.05% (64/ 82 ) and 80.49% ( 66/82 ) in human colorectal carcinoma, respectively, which were significant higher than those in adjacent nonneoplastic tissues. The expression of MinaS3 and Ki -67 was related to the Duke's stage, the P value is 0.029 and 0.037, respectively. There was no obvious correlation between the expression and the age, tumor size and the pathological grade;univariate analysis of Cox proportional hazards regression model revealed that the ex- pression of MinaS3 and the stage were relevant to prognosis, the P value was 0. 039 and 0. 000, respectively. Condusion Overexpressions of MinaS3 and Ki -67 were found in the eolorectal carcinoma compared with no expression in the adjacent nonneoplastic tissues, and this maybe illustrate the invasion and metastasis of the tumor. MinaS3 maybe serve as a prognostic factor of colorectal carcinoma.
作者 李爽 陈元
出处 《实用肿瘤学杂志》 CAS 2011年第6期537-543,共7页 Practical Oncology Journal
关键词 大肠癌 免疫组化 MINA53 KI-67 Colorectal carcinoma Immunohistochemistry MinaS3 Ki - 67
  • 相关文献

参考文献19

  • 1Tsuneoka M, Koda Y, Soejima M, et al. A novel Myc target gene, MinaS3, that is involved in cell proliferaration [ J ]. J Biol Chem,2002,277 (38) : 35450 - 35459.
  • 2Teye K, Tsuneoka M, Arima N, et al. Increased expression of a Myc target gene MinaS3 in human colon cancer[ J]. Am J patho1,2004,164( 1 ) :205 - 216.
  • 3Tsuneoka M, Fujita H, Arima N, et al. Mina 53 as a poten- tial prognostic factor for esophageal squamous cell carcino- ma[ J ]. Clin Cancer Res ,2004,10 (21) :7347 - 7356.
  • 4Teye K, Arima N, Nakamura Y, et al. Expression of Myc targe gene MinaS3 in subtypes of human lymphoma [ J ]. Oncol Rep,2007,18(4) :841 - 848.
  • 5Ishizaki H, Yano H, Tsuneoka M, et al. Overexpression of the myc target gene MinaS3 in advqanced renal cell carcino- ma [ J ]. Pathology international ,2007,57:672 - 680.
  • 6Fukahori S, Yano H, Tsuneoka M, et al. Immunohistochemi- cal expression of Cap43 and Mina53 proteins in neuroblasto- ma[ J]. J Pediatr surg,2007,42( 11 ) :1831 - 1840.
  • 7Zhang Q, Hu CM, Yuan YS, et al. Expressin of Mina53 and its significance in gastric carcinoma[ J]. Int J Biol Markers, 2008,23(2) :83 -88.
  • 8Komiya K, Sueoka - Aragane N, Sato A, et al. Mina53, a no- vel c -Mye target gene, is frequently expressed in lung cancers and exerts oncogenic property in NIH/3T3 cells [J]. J Cancer Res Clin 0ncol,2010,136(3):465 -473.
  • 9Komiya K, Sueoka - Aragane N, Sato A, et al. Expression of MinaS3, a novel c - Myc target gene,is a favorable prognos- tic marker in early stage lung cancer [ J ]. Lung Cancer, 2009,13(10) :10.
  • 10Ogasawara S, Komuta M, Nakashima O, et al. Accelerated expression of a Myc target gene MinaS3 in aggressive hepa- tocellular carcinoma[ J]. Hepatol Res ,2010,40(3 ) :330 -336.

二级参考文献10

共引文献31

同被引文献56

  • 1蔡善荣,郑树,张苏展.842例大肠癌生存状况及其影响因素的多因素分析[J].实用肿瘤杂志,2005,20(1):40-43. 被引量:13
  • 2杨艳芳,李佩珍,梁小波,韩晓立,李耀平,丛娟.根治术大肠癌预后因素和个体预后预测模型的研究[J].中华流行病学杂志,2005,26(3):214-217. 被引量:4
  • 3黄玮,吴云林.大肠侧向发育型肿瘤研究进展[J].中华消化杂志,2006,26(7):500-502. 被引量:12
  • 4周涛,韩彧,巩伟丽,赵春林.活体动物体内成像技术及其在生物医学中的应用进展[J].中国体视学与图像分析,2007,12(1):69-74. 被引量:7
  • 5Scanlan MJ,Gure AO,Jungbluth AA,et al. Cancer/testls antigens :an expanding family of targets for cancer im- munotherapy [J]. Immunological Reviews,2002,188:22732.
  • 6Blattman JN ,Greenberg PD. Cancer immunotherapy :a treat- ment for the masses [J]. Science, 2004,305 (5681) : 200- 205.
  • 7Nagrath S ,Sequist LV, Maheswaran S,et al. Isolation of rare circulating tumour cells in cancer patients by microchip technology [J]. Nature, 2007,450 (7173 ) : 1235 - 1239.
  • 8Li Y,Zeng H,Xu RH,et al. Vaccination with human pluripo- tent stem ceils generates a broad spectrum of immunological and clinical responses against colon cancer [J]. Stern Cells, 2009,27(12) :3103-3111.
  • 9Minguell JJ ,Erices A,Conget P. Mesenchymal stem ceils [J]. Experimental Biology and Medicine,2001,226(6) :507-520.
  • 10Parish CR. Cancer immunotherapy:the past,the present and the future [J]. Immunology and Cell Biology,2003,81 (2): 106-113.

引证文献6

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部